Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 9Parkinson Disease 4, Autosomal Dominant Lewy Body 4Urinary Bladder Neoplasms 3Urologic Neoplasms 2Kidney Neoplasms 2Carcinoma, Renal Cell 2Pain, Postoperative 1Non-Muscle Invasive Bladder Neoplasms 1Erectile Dysfunction 1Carcinoma, Transitional Cell 1

Interventions

Gemcitabine 9pembrolizumab 7Cisplatin 5enfortumab vedotin 4atezolizumab 4Trastuzumab 4Mitomycin 4Carboplatin 4Sunitinib 3Pemetrexed 3dodecyl maltoside 2cabozantinib 2Water 2Sugammadex 2Standard of Care 2Saline Solution 2Paclitaxel 2Nivolumab 2Neostigmine 2Docetaxel 2Cetuximab 2Bevacizumab 2zidovudine 5'-monophosphate-mannose-albumin conjugate 1vinflunine 1valrubicin 1tucatinib 1tislelizumab 1testosterone 17 beta-cypionate 1temsirolimus 1relatlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Urologic Neoplasms × Saline Solution × Genitourinary × Clear all
NCT03359239 2023-05-16

Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer

Icahn School of Medicine at Mount Sinai

Phase 1 Completed
10 enrolled
Genitourinary

Urologic Neoplasms

NCT04840511 2023-01-13

The Effect of Perioperative Lidocaine Infusion on Neutrophil Extracellular Trapping

The Catholic University of Korea

Phase NA Active not recruiting
60 enrolled
Genitourinary

Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡